SCHEMBL7959160

SCHEMBL7959160

CCCOc1ccc(C(=O)CN2CCN(C)CC2)cc1-c1nc2c(CCC)nn(C)c2c(=O)[nH]1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 20/20 0.77
PDE6C P51160 3/20 0.77
PDE3B Q13370 2/20 0.60
PDE3A Q14432 2/20 0.60
PDE2A O00408 1/20 0.60
ABCC4 O15439 1/20 0.60
ABCC5 O15440 1/20 0.60
PDE6D O43924 1/20 0.60
PDE8A O60658 1/20 0.60
PDE9A O76083 1/20 0.60
ABCB11 O95342 1/20 0.60
CYP3A4 P08684 1/20 0.60
HTR1A P08908 1/20 0.60
PDE6A P16499 1/20 0.60
PDE6G P18545 1/20 0.60
PDE4A P27815 1/20 0.60
ADORA2A P29274 1/20 0.60
ADORA1 P30542 1/20 0.60
ADRA1A P35348 1/20 0.60
PDE6B P35913 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18069561 0.95 PDE5A (0.77) PDE5APDE6CPDE3BPDE3AHDAC1
SCHEMBL25013469 0.94 PDE5A (0.85) PDE5APDE6CPDE3BPDE3APDE2A
SCHEMBL30199753 0.94 PDE5A (0.85) PDE5APDE6CPDE3BPDE3APDE2A
SCHEMBL146830 0.92 PDE5A (0.90) PDE5APDE6CHDAC1HDAC6HDAC2
SCHEMBL29611957 0.92 PDE5A (0.90) PDE5APDE6CHDAC1HDAC6HDAC2
SCHEMBL2693448 0.90 PDE5A (0.85) PDE5APDE6CPDE3BPDE3APDE2A
SCHEMBL29357402 0.90 PDE5A (0.85) PDE5APDE6CPDE3BPDE3APDE2A
SCHEMBL7965731 0.89 PDE5A (0.84) PDE5APDE6CPDE3BPDE3APDE2A
SCHEMBL28482244 0.88 PDE5A (0.83) PDE5APDE6CPDE3BPDE3APDE2A
SCHEMBL7964961 0.88 PDE5A (0.85) PDE5APDE6CPDE3BPDE3APDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111297868-A Use of a composition comprising a heterocyclic compound for the manufacture of a medicament for the treatment of phosphodiesterase mediated diseases 黄泳华 2020-06-19 CN claimed
CN-111297868-A Use of a composition comprising a heterocyclic compound for the manufacture of a medicament for the treatment of phosphodiesterase mediated diseases 黄泳华 2020-06-19 CN disclosed
US-6200980-B1 ADMINISTERING PHENYL PURINONE COMPOUND FOR TREATING PRECANCEROUS LEISONS CELL PATHWAYS, INC. 2001-03-13 US disclosed
EP-0526004-B1 Pyrazolopyrimidinone antianginal agents PFIZER LTD (GB) 1997-10-08 EP disclosed
US-5426107-A Treatment of cardiovascular disorders, asthma, allergies PFIZER INC. (US) 1995-06-20 US disclosed
EP-0526004-A1 Pyrazolopyrimidinone antianginal agents Pfizer Limited (GB) 1993-02-03 EP disclosed